IRIS
ROMANO, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.826
EU - Europa 1.360
AS - Asia 192
SA - Sud America 2
Totale 3.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.822
GB - Regno Unito 383
IE - Irlanda 324
SE - Svezia 197
CN - Cina 183
UA - Ucraina 176
DE - Germania 84
FR - Francia 77
FI - Finlandia 53
IT - Italia 19
BE - Belgio 12
ES - Italia 12
RU - Federazione Russa 9
CA - Canada 4
SG - Singapore 4
LU - Lussemburgo 3
BR - Brasile 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
ME - Montenegro 1
MY - Malesia 1
PL - Polonia 1
Totale 3.380
Salva come PNG Salva come JPEG
Città #
Southend 337
Dublin 322
Fairfield 253
Chandler 216
Ashburn 161
Ann Arbor 144
Jacksonville 143
Woodbridge 123
Seattle 93
Wilmington 85
Cambridge 71
Houston 70
Menlo Park 60
New York 55
Princeton 49
Nanjing 45
Beijing 29
Shanghai 25
Boardman 24
Helsinki 22
San Mateo 17
Nanchang 15
San Diego 14
Brussels 12
Málaga 12
Hebei 10
Tianjin 9
Kunming 8
Moscow 8
London 7
Siena 7
Changsha 6
Jiaxing 6
Düsseldorf 5
Norwalk 5
Shenyang 5
Changchun 4
Jinan 4
Munich 4
Redwood City 4
Zhengzhou 4
Hangzhou 3
Kilburn 3
Luxembourg 3
Toronto 3
Chiswick 2
Edinburgh 2
Lancaster 2
Mestre 2
Philadelphia 2
San Francisco 2
Singapore 2
Taizhou 2
Tel Aviv 2
Wandsworth 2
Washington 2
Acton 1
Amsterdam 1
Athens 1
Atlanta 1
Auburn Hills 1
Brno 1
Budapest 1
Charlotte 1
Copenhagen 1
Dubai 1
Evanston 1
Falkenstein 1
Groningen 1
Guangzhou 1
Hounslow 1
Indiana 1
Islington 1
Kuala Lumpur 1
Lambeth 1
Lanzhou 1
Lappeenranta 1
Leawood 1
Los Angeles 1
Montreal 1
Paris 1
Podgorica 1
Prague 1
Qingdao 1
Redmond 1
Rome 1
Stockholm 1
Surabaya 1
São Paulo 1
Tallinn 1
Tappahannock 1
Trani 1
Venezia 1
Warsaw 1
Totale 2.565
Salva come PNG Salva come JPEG
Nome #
Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple 158
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type 1 nucleoside reverse transcriptase inhibitors 144
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors 142
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. 141
Identification of a Possible Ancestor of the Subtype A1 HIV Type 1 Variant Circulating in the Former Soviet Union 137
Lack of evidence of HHV-8 DNA in blood cells from heart transplant recipients 135
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment 135
Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens. 132
Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy 130
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. 129
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy. 129
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. 124
Focal myositis: a polymerase chain reaction analysis for a viral etiology 123
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. 122
Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors. 119
Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors 117
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives 117
Evidence of differential selection of HIV-1 variants carrying drug resistant mutations in seroconverters 115
Both HIV Cellular DNA and Plasma RNA Sequencing are Useful for Detection of Drug Resistance Mutations in Antiretroviral Naive Patients. 101
Heterozygosity for the CCR-5 ƒ´32 deletion, HIV-1 transmission and disease progression. 97
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy 97
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells 95
Detection of a drug-resistant HIV variant in a newly infected heterosexual couple 94
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA. 88
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy 87
Use of peripheral blood DNA for genotypic antiretroviral resistance testing in drug-naïve HIV-infected subjects. 84
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 82
Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma 78
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 67
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of HIV-1 unique recombinant forms 66
Totale 3.385
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020675 94 25 47 123 43 40 42 87 60 49 13 52
2020/2021446 25 59 6 49 17 64 10 74 65 18 37 22
2021/2022341 25 37 18 45 28 3 19 16 14 39 26 71
2022/2023681 30 74 74 101 76 133 7 63 68 17 29 9
2023/2024506 12 16 47 45 15 172 174 9 3 2 0 11
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 3.385